The EU General Pharmaceutical Legislation (GPL) will fundamentally change the life sciences ecosystem in Europe. As proposed, the legislation is a step back from Europe's historically strong support for IP protections. That policy shift compromises the EUs ambition to build a competitive and knowledge-based economy.
Life Science Acceleration Alliance e.V
NGO · Germany · EU Transparency Register 320028947950-50
Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.
Who they are
Among the 1365 trade and business associations on this site, they rank #1256 by legislative files engaged — a count of participation, not a measure of influence.
- Register category
- Trade and business associations
- Registered as
- Life Sciences Acceleration Alliance e.V (LSAA)
- Head office
- Munich, Germany
Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.
Track Life in PolicySpeak: request access →
Work at Life Science Acceleration Alliance e.V? so we know who speaks for it.
Their record over time
Life Science Acceleration Alliance e.V filed 1 position on 5 Sept 2023, across 1 of the 583 legislative files tracked here, attaching a full position paper 1 time.
What they argued
Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.
Put Life Science Acceleration Alliance e.V next to another organization. Same files, same register facts, side by side. Compare →
Is this your organization?
Everything on this page comes from Life Science Acceleration Alliance e.V’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.
Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.